Listing analysis and research matching Inifinity:
AstraZeneca's acquisition of Medimmune
AstraZeneca's recent acquisition of Medimmine will affect the future of companies like Infinity Pharmaceuticals, Medarex, Critical Therapeutics, Biota Holdings who have partnerships with MedImmune in a range of areas including oncology, respiratory disease, infectious diseases and lupus. AstraZeneca's plan to merge MedImmune with Cambridge Antibody Technology will be watched keenly by partners in this space.
